Galmed Pharmaceuticals Ltd. (GLMD) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2025)

$6.9M

Total Assets (FY2025)

$18.6M

Total Equity (FY2025)

$15.8M

Cash Flows from Operating Activities (FY2025)

-$6.3M

Source: Galmed Pharmaceuticals Ltd. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.